Jeffrey Riley

Chief Executive Officer

Jeffrey Riley is a high-level professional, working in Blinktbi on the position of Chief Executive Officer since 2020. Jeffrey Riley gained professional experience in more than five positions at various companies. Jeffrey Riley went to the Stanford Law School and received education from 2014 to 2015. Boise, Idaho is the area, where this expert was lastly known to be situated. This professional's email address and number are accessed through this website on demand.
Name variants:
Jeffery Riley, Geoffrey Riley, Jeff Riley
Last updated May 25, 2024

Contact Information

Last Update
Jul 11, 2022
Email
je**@sci-ops.com, jr**@syntheticbiologics.com
Location
Boise, ID
Company
Blinktbi

Workplace

Chief Executive Officer

Work History

Chief Executive Officer

from Aug 2020

Board of Directors - Independent

Biotechnology company developing next-generation pharmacological chaperones for the treatment of devastating rare diseases.
from May 2019

Partner and Founder

Strategic and management consulting and investing for pharmaceutical, biotechnology, life sciences, and diagnostic companies. Co-founded 526 and worked in this role from 2010-2014.
from Jan 2018

Ceo, Synthetic Biologics, Inc

9605 Medical Center Dr SUITE 270, Rockville, MD 20850
Mr. Riley has been a director of the Company since March 16, 2010, and has served as CEO since February 2012. He has more than 20 years of experience in the biotechnology and pharmaceutical ...
Feb 1, 2012 — Dec 2017

Member Board of Directors

54 Girard St SUITE A, Durango, CO 81303
Pioneering custom medical solutions for the harshest environments on earth. Specialized health gear for U.S. Special Forces, SWOT, firefoghters etc. https://www.chinookmed.com/
from Mar 2016

Occupations

Executive
Chief Executive Officer
Scientist
Biotechnology Professional
Board Member
Corporate Executive
Chief Executive
Biologist
Biological Scientist
Management Team Executive
Operations Manager

Skills

Venture Capital
Biotechnology
Strategy
Management
Pharmaceutical Industry
Life Sciences
Start Ups
Mergers and Acquisitions
Investments
Drug Discovery
Executive Management
Product Development
Corporate Development
Technology Transfer
Private Equity
Lifesciences
Medical Devices
Due Diligence
Oncology
Joint Ventures
Business Development
Business Strategy
Mergers
Drug Development
Entrepreneurship
Immunology
Competitive Analysis
Market Research
Strategic Partnerships
Cross Functional Team Leadership
Valuation
Patents
R&D
Acquisition Integration
Cro
Financial Analysis
Finance
Hardware Diagnostics
Business Planning
Market Analysis
Investment Banking
Genomics
Infectious Diseases
Ipo
Fda
Alternative Investments
Login